This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Rob Freishat
President at Uncommon Cures
Speaker

Profile

Dr. Rob Freishtat is a highly regarded physician-executive known for his transformative impact on biotechnology ventures, clinical medicine, and international healthcare initiatives. With a professional history spanning over two decades, Dr. Freishtat has consistently demonstrated his ability to lead high-stakes organizational transformations, drive clinical solutions to the marketplace, and forge strategic global partnerships. As the President and Co-Founder of Uncommon Cures, Dr. Freishtat has transformed clinical trials for rare diseases by implementing a unique trial model that eliminates inefficiencies and accelerates the path to drug approval.

Agenda Sessions

  • Funding Opportunities – A Discussion with Diverse Stakeholders

    2:15pm